medigraphic.com
ISSN 2007-8013 (Impreso)
Órgano oficial de la Universidad Autónoma de Sinaloa

2022, Número 2

<< Anterior Siguiente >>

Rev Med UAS 2022; 12 (2)


Incremento en la mineralización valvular aórtica en pacientes con diabetes mellitus

Paniagua-Ávila AR, Bolívar-Carlos MA, Corona-Sapien F

Idioma: Español
Referencias bibliográficas: 35
Paginas: 143-156
Archivo PDF: 297.79 Kb.


RESUMEN

La estenosis aórtica y la diabetes mellitus son enfermedades crónico-degenerativas que tienen un impacto importante en la morbi-mortalidad a nivel mundial. En las últimas décadas se ha presentado mayor prevalencia de estenosis aórtica en pacientes con dia-betes mellitus. El riesgo de la progresión a enfermedad grave de la estenosis aórtica aumenta en estos pacientes, condicionando a reemplazo valvular como el único tratamiento. Por lo tanto, se requiere de comprensión extensa de la patogénesis de ambas enfer-medades y la relación entre estas para designar abordajes preventivos y terapéuticos. Este artículo de revisión busca la comprensión y actualización de la influencia de la diabetes mellitus en pacientes con estenosis aórtica degenerativa, así como la progresión de la enfermedad y el abordaje diagnóstico y terapéutico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mourino-Alvarez L, Corbacho-Alonso N, Sastre-Oliva T, Corros-Vicente C, Solis, J, Tejerina T, et al. Diabetes Mellitus and Its Implications in Aortic Stenosis Patients. Int J Mol Sci. 2021;22(12):6212.

  2. Stritzke J, Linsel-Nitschke P, Markus MR, Mayer B, Lieb W, Luchner A, et al. Associa-tion between degenerative aortic valve di-sease and long-term exposure to cardiovas-cular risk factors: Results of the longitudinal population-based KORA/MONICA survey. Eur Heart J. 2009;30(16):2044-53.

  3. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med. 2007;4(5):254-62.

  4. Banovic M, Athithan L, McCann GP. Aortic stenosis and diabetes mellitus: An ominous combination. Diab Vasc Dis Res. 2019;16(4):310-23.

  5. Tango AM, Salmonsmith J, Ducci A, Bu-rriesci G. Validation and Extension of a Fluid–Structure Interaction Model of the Healthy Aortic Valve. Cardiovasc Eng Tech-nol. 2018;9(4):739-51.

  6. De Paulis R, Salica A. Surgical anatomy of the aortic valve and root-implications for valve repair. Ann Cardiothorac Surg. 2019;8(3):313-21.

  7. Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de dia-betes por diagnóstico médico previo en Mé-xico. Salud Publica Mex. 2018;60(3):224-32.

  8. Kopytek M, Ząbczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced gly-cation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardio-vasc Diabetol. 2020;19(1):92.

  9. Larsson SC, Wallin A, Håkansson N, Sta-ckelberg O, Bäck M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of se-ven cardiovascular diseases. Int J Cardiol. 2018;262:66-70

  10. Dutta P, Lincoln J. Calcific Aortic Valve Di-sease: a Developmental Biology Perspec-tive. Curr Cardiol Rep. 2018;20(4):21.

  11. Mathieu P, Boulanger MC. Basic mecha-nisms of calcific aortic valve disease. Can J Cardiol. 2014;30(9):982-93.

  12. Fernandez-Tresguerres Hernandez-Gil I, Alobera Gracia MA, Del Canto Pingarrón M, Blanco Jerez L. Bases fisiológicas de la re-generación ósea II. El proceso de remode-lado. Med Oral Patol Oral Cir Bucal. 2006;11(2):92-8.

  13. Bertazzo S, Gentleman E. Aortic valve calci-fication: A bone of contention. Eur Heart J. 2017;38(16):1189-93.

  14. Testuz A, Nguyen V, Mathieu T, Kerneis C., Arangalage, D, Kubota N. et al. Influence of metabolic syndrome and diabetes on pro-gression of calcific aortic valve stenosis. Int J Cardiol. 2017;244:248-53.

  15. Zheng KH, Tsimikas S, Pawade T, Kroon J, Jenkins WSA, Doris MK, et al. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis. J Am Coll Cardiol. 2019;73(17):2150-62.

  16. Carrion K, Dyo J, Patel V, Sasik R, Moha-med SA, Hardiman G, et al. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS One. 2014;9(5):e96577.

  17. Coffey S, Cox B, Williams MJ. The preva-lence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2852-61.

  18. Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.

  19. Rogers MA, Aikawa E. Cardiovascular calci-fication: artificial intelligence and big data ac-celerate mechanistic discovery. Nat Rev Cardiol. 2019;16(5):261-74.

  20. Thaden JJ, Nkomo VT, Enriquez-Sarano M. The Global Burden of Aortic Stenosis. Prog Cardiovasc Dis. 2014;56(6):565-71.

  21. Singh A, Chan DCS, Greenwood JP, Daw-son DK, Sonecki P, Hogrefe K, et al. Sym-ptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remode-ling. JACC Cardiovasc Imaging. 2019;12(1):96-105.

  22. Vollema EM, Sugimoto T, Shen M, Tastet L, Ng ACT, Abou R, et al. Association of Left Ventricular Global Longitudinal Strain With Asymptomatic Severe Aortic Stenosis: Natu-ral Course and Prognostic Value. JAMA Car-diol. 2018;•(9):839-47.

  23. Zheng KH, Tzolos E, Dweck MR. Pathop-hysiology of Aortic Stenosis and Future Perspectives for Medical Therapy. Cardiol Clin. 2020;38(1):1-12.

  24. Jander N, Minners J, Holme I, Gerdts E, Bo-man K, Brudi P, et al. Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction. Circulation. 2011;123(8):887-95.

  25. White B, Wessel S, Zheng W, Gonzalez D, Sovari A, Konda S, et al. Quantitative analysis of spectral Doppler clicks in assess-ment of aortic stenosis. Echocardiography. 2019;36(12):2158-66.

  26. Joseph J, Naqvi SY, Giri J, Goldberg S. Aortic Stenosis: Pathophysiology, Diagno-sis, and Therapy. Am J Med. 2017;130(3):253-63.

  27. Langanay T, Rouzé S, Tomasi J, Aymami M, Rehman SM, Anselmi A, et al. Conventional aortic valve replacement in 2005 elderly pa-tients: A 32-year experience. Eur J Cardiot-horac Surg. 2018;54(3):446-52.

  28. Otto CM, Nishimura RA, Bonow RO, Cara-bello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: Execu-tive Summary: A Report of the American Co-llege of Cardiology/American Heart Associa-tion Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71.

  29. Nishimura RA, Otto CM, Bonow RO, Cara-bello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC Guideline for the Manage-ment of Patients With Valvular Heart Di-sease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440-92.

  30. Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, et al. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. N Engl J Med. 2020;382(2):111-9.

  31. Mathieu P, Boulanger MC, Bouchareb R. Molecular biology of calcific aortic valve di-sease: towards new pharmacological thera-pies. Expert Rev Cardiovasc Ther. 2014;12(7):851-62.

  32. Sen J, Chung E, Neil C, Marwick T. Antihy-pertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysis. BMJ Open. 2020;10:e036960.

  33. Kodali SK, Williams MR, Smith CR, Svens-son LG, Webb JG, Makkar RR, et al. Two-Year Outcomes after Transcatheter or Sur-gical Aortic-Valve Replacement. N Engl J Med. 2012;366(18):1686-95.

  34. Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-Year Outcomes of Transcatheter or Surgical Aor-tic-Valve Replacement. N Engl J Med. 2020;382(9):799-809.

  35. Wernly B, Zappe AK, Unbehaun A, Sinning JM, Jung C, Kim WK, et al. Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves. Clin Res Cardiol. 2019;108(1):83-92.




2020     |     www.medigraphic.com